Erratum

CORRIGENDUM: Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria. Aisha A. Galadanci, Najibah A. Galadanci, Binta W. Jibir, et al. Am J Hematol. 2019;94(11):E305-E307. https://doi.org/10.1002/ajh.25616

CORRIGENDUM: The original article which appeared in Am J Hematol, 94(11):E305-E307 contains one error in Table 1: for the Column: “Children with SCA (age: 0-12 years) evaluated weekly, N” the value for Murtala Muhammad Specialist Hospital should be > 360 instead of 160. The authors apologize for any confusion regarding this point.